The pharmaceutical community is buzzing by retatrutide, a novel dual GIP and GLP-1 agonist that’s showing significant results in early studies . This medication works by replicating natural hormones to affect appetite and increase feelings of satiety, ultimately contributing to substantial weight decrease. While currently under investigation and